Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 213

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 213
---
 group (9 persons) |     |                                                      | 21,698,200 | -11 |     |                        | 50.8 |
| Other 5% Stockholders:                                      |     |                                                      |            |     |     |                        |      |
| Claes Wahlestedt, M.D., Ph.D.                               |     |                                                      |  3,333,814 | -12 |     |                        |  9.5 |
| Shaun Brothers                                              |     |                                                      |  2,038,970 | -13 |     |                        |  5.9 |

| * | less than 1%. |

| (1) | The percentages in the table have been calculated based on 34,426,355                                                                   
 shares of our common stock outstanding on November 25, 2025. To calculate a stockholder’s percentage of beneficial ownership,           
 we include in the numerator and denominator the common stock outstanding and all shares of our common stock issuable to that person     
 in the event of the exercise of outstanding options and other derivative securities owned by that person which are exercisable within   
 60 days of November 25, 2025. Common stock options and derivative securities held by other stockholders are disregarded in              
 this calculation. Therefore, the denominator used in calculating beneficial ownership among our stockholders may differ. Unless we      
 have indicated otherwise, each person named in the table has sole voting power and sole investment power for the shares listed opposite 
 such person’s name.                                                                                                                     |

| (2) | Includes 497,392 and 2,003,678 shares of common stock that may be acquired                                
 within 60 days of November 25, 2025 upon conversion or exercise of vested RSUs and options, respectively. |
| (3) | Includes 389,793 and 1,245,098 shares of common stock that may be acquired                                
 within 60 days of November 25, 2025 upon conversion or exercise of vested RSUs and options, respectively. |
| (4) | Includes 66,292 and 666,420 shares of common stock that may be acquired                                   
 within 60 days of November 25, 2025 upon conversion or exercise of vested RSUs and options, respectively. |

| 121 |

| (5)  | Includes 110,227 and 870,871 shares of common stock that may be acquired                                                                                                                                                                                                                 
 within 60 days of November 25, 2025 upon conversion